Heineken warned that popular weight-loss treatments like Ozempic and Wegovy could reduce overall beverage intake. The brewer advised United Kingdom on-trade venues to offer smaller serving sizes and non-alcoholic alternatives to defend revenues.
Read the full report at El Imparcial
Summary written by Distillers Hub from the original report. Spotted an error? Tell us.